ATE404541T1 - Xanthinoxidaseinhibitoren - Google Patents
XanthinoxidaseinhibitorenInfo
- Publication number
- ATE404541T1 ATE404541T1 AT02780099T AT02780099T ATE404541T1 AT E404541 T1 ATE404541 T1 AT E404541T1 AT 02780099 T AT02780099 T AT 02780099T AT 02780099 T AT02780099 T AT 02780099T AT E404541 T1 ATE404541 T1 AT E404541T1
- Authority
- AT
- Austria
- Prior art keywords
- xanthine
- oxidasine
- inhibitors
- substituent
- carboxyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001352340 | 2001-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE404541T1 true ATE404541T1 (de) | 2008-08-15 |
Family
ID=19164532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02780099T ATE404541T1 (de) | 2001-11-16 | 2002-11-14 | Xanthinoxidaseinhibitoren |
Country Status (11)
Country | Link |
---|---|
US (2) | US7253154B2 (de) |
EP (1) | EP1452528B1 (de) |
JP (2) | JP4634037B2 (de) |
KR (1) | KR100919147B1 (de) |
CN (2) | CN100338040C (de) |
AT (1) | ATE404541T1 (de) |
DE (1) | DE60228316D1 (de) |
DK (1) | DK1452528T3 (de) |
ES (1) | ES2309213T3 (de) |
PT (1) | PT1452528E (de) |
WO (1) | WO2003042185A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2312857T3 (es) * | 2002-12-19 | 2009-03-01 | The Scripps Research Institute | Composiciones y metodos para estabilizar la transtiretina e inhibir el mal replegamiento de la transtiretina. |
EP1751159A2 (de) * | 2004-04-28 | 2007-02-14 | Cv Therapeutics, Inc. | Purinderivate als a1-adenosinrezeptorantagonisten |
ATE512154T1 (de) | 2004-06-14 | 2011-06-15 | Nippon Chemiphar Co | Kondensiertes pyrimidinderivat und xanthinoxidaseinhibitor |
KR101191071B1 (ko) | 2004-06-14 | 2012-10-15 | 닛뽕 케미파 가부시키가이샤 | 축합 피리미딘 유도체 및 크산틴 옥시다제 저해제 |
US8557831B2 (en) * | 2004-07-21 | 2013-10-15 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of insulin resistance |
KR20080035594A (ko) * | 2005-07-01 | 2008-04-23 | 닛뽕 케미파 가부시키가이샤 | 크산틴옥시다아제 저해제 |
CN102429907B (zh) * | 2006-06-22 | 2013-08-21 | 日本化学医药株式会社 | 抗癌药耐性克服剂 |
WO2008034016A2 (en) * | 2006-09-15 | 2008-03-20 | Foldrx Pharmaceuticals, Inc. | Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins |
CN101679244B (zh) * | 2007-04-11 | 2014-01-01 | 橘生药品工业株式会社 | 5元杂环衍生物及其医药用途 |
EP2165705A1 (de) | 2008-09-18 | 2010-03-24 | Centre National de la Recherche Scientifique (CNRS) | Verwendung einer Verbindung mit der Fähigkeit zur Senkung des Harnsäureniveaus zur Prävention und/oder Behandlung von Lungenentzündung und -fibrose |
JP5673008B2 (ja) | 2010-08-11 | 2015-02-18 | ソニー株式会社 | 画像処理装置、立体画像表示装置および立体画像表示システム、ならびに立体画像表示装置の視差ずれ検出方法および立体画像表示装置の製造方法 |
CN102095825B (zh) * | 2010-12-08 | 2014-07-23 | 中国科学院长春应用化学研究所 | 超高效液相色谱和质谱联用筛选黄嘌呤氧化酶抑制剂的方法 |
BR112014005810A2 (pt) | 2011-09-16 | 2017-03-28 | Pfizer | formas sólidas de um inibidor da dissociação de transtirretina |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
WO2014151729A1 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
NZ721650A (en) | 2013-12-19 | 2018-12-21 | Novartis Ag | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
JP2017048116A (ja) * | 2014-01-10 | 2017-03-09 | 国立研究開発法人国立国際医療研究センター | 肺高血圧症治療薬 |
CN107427517B (zh) | 2015-02-24 | 2021-11-16 | 国立大学法人鸟取大学 | 用于痴呆症的预防及/或治疗的医药 |
CN106146533B (zh) * | 2016-07-14 | 2018-04-03 | 华润赛科药业有限责任公司 | 含硫杂环羧酸类衍生物、其制备方法和应用 |
WO2020009374A1 (ko) * | 2018-07-04 | 2020-01-09 | 고려대학교 세종산학협력단 | 4-치환 옥사졸로퀴놀리논 유도체, 약학적으로 허용되는 이의 염인 화합물 및 이를 유효성분으로 포함하는 천식 또는 아토피 등의 알러지성 질환의 예방 또는 치료용 약학 조성물 |
CN110283137A (zh) * | 2019-06-13 | 2019-09-27 | 爱斯特(成都)生物制药股份有限公司 | 一种2-(4-溴苯基)-1,3-苯并恶唑的制备方法 |
CN111620833A (zh) * | 2020-06-05 | 2020-09-04 | 青岛伯川特聚科技有限公司 | 一种2-苯基苯并噁唑类化合物的制备方法 |
CN113004188B (zh) * | 2021-03-16 | 2022-09-20 | 沈阳药科大学 | 一种吲哚衍生物及制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4038396A (en) * | 1975-02-24 | 1977-07-26 | Merck & Co., Inc. | Anti-inflammatory oxazole[4,5-b]pyridines |
DE2927988A1 (de) * | 1979-07-11 | 1981-02-05 | Thomae Gmbh Dr K | Neue 8-phenyl-purine, deren herstellung und deren verwendung als arzneimittel |
RO86850B (ro) * | 1982-05-03 | 1985-05-31 | Eli Lilly And Company | Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine |
JPS62246581A (ja) * | 1986-04-17 | 1987-10-27 | Chugai Pharmaceut Co Ltd | フロベンゾオキサゾ−ル誘導体 |
NZ221729A (en) * | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
JPH03258770A (ja) * | 1990-03-08 | 1991-11-19 | Tanabe Seiyaku Co Ltd | ベンズアゾール誘導体、その製法及びその合成中間体 |
JP3176073B2 (ja) * | 1990-06-19 | 2001-06-11 | キヤノン株式会社 | 液晶素子 |
JP2004503553A (ja) * | 2000-06-14 | 2004-02-05 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 6,5−縮合二環式複素環 |
MXPA02011396A (es) * | 2000-06-14 | 2003-04-25 | Warner Lambert Co | Inhibidores de indol y bencimidazol 15-lipoxigenasa. |
GB0205256D0 (en) | 2002-03-06 | 2002-04-17 | Oxford Glycosciences Uk Ltd | Novel compounds |
-
2002
- 2002-11-14 PT PT02780099T patent/PT1452528E/pt unknown
- 2002-11-14 EP EP02780099A patent/EP1452528B1/de not_active Expired - Lifetime
- 2002-11-14 CN CNB028272056A patent/CN100338040C/zh not_active Expired - Fee Related
- 2002-11-14 JP JP2003544021A patent/JP4634037B2/ja not_active Expired - Fee Related
- 2002-11-14 DE DE60228316T patent/DE60228316D1/de not_active Expired - Lifetime
- 2002-11-14 ES ES02780099T patent/ES2309213T3/es not_active Expired - Lifetime
- 2002-11-14 US US10/495,844 patent/US7253154B2/en not_active Expired - Lifetime
- 2002-11-14 KR KR1020047007333A patent/KR100919147B1/ko active IP Right Grant
- 2002-11-14 DK DK02780099T patent/DK1452528T3/da active
- 2002-11-14 WO PCT/JP2002/011893 patent/WO2003042185A1/ja active IP Right Grant
- 2002-11-14 CN CNA2007101369545A patent/CN101092400A/zh active Pending
- 2002-11-14 AT AT02780099T patent/ATE404541T1/de active
-
2007
- 2007-07-27 US US11/829,286 patent/US20070265283A1/en not_active Abandoned
-
2010
- 2010-04-06 JP JP2010088128A patent/JP5297414B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20050090472A1 (en) | 2005-04-28 |
ES2309213T3 (es) | 2008-12-16 |
JP5297414B2 (ja) | 2013-09-25 |
JPWO2003042185A1 (ja) | 2005-03-10 |
CN100338040C (zh) | 2007-09-19 |
DE60228316D1 (en) | 2008-09-25 |
US20070265283A1 (en) | 2007-11-15 |
PT1452528E (pt) | 2008-10-14 |
EP1452528B1 (de) | 2008-08-13 |
CN1615299A (zh) | 2005-05-11 |
CN101092400A (zh) | 2007-12-26 |
EP1452528A1 (de) | 2004-09-01 |
KR20040065223A (ko) | 2004-07-21 |
JP4634037B2 (ja) | 2011-02-16 |
DK1452528T3 (da) | 2008-11-10 |
EP1452528A4 (de) | 2005-11-16 |
JP2010180232A (ja) | 2010-08-19 |
KR100919147B1 (ko) | 2009-09-25 |
US7253154B2 (en) | 2007-08-07 |
WO2003042185A1 (fr) | 2003-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1452528T3 (da) | Xanthinoxidaserinhibitorer | |
NZ505968A (en) | Sulfonylamino derivatives which inhibit matrix- degrading metallproteinases | |
ATE345122T1 (de) | Stabile emulsionszubereitungen | |
EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
CA2432713A1 (en) | Aniline derivatives or salts thereof and cytokine production inhibitors containing the same | |
DK0787726T3 (da) | Ny forbindelse, fremgangsmåde til fremstilling deraf og antitumor-middel | |
AU2003246100A1 (en) | Amide derivative | |
DE69332792D1 (de) | 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide | |
NO20004485D0 (no) | Sykloalkenderivater, deres fremstilling og anvendelse | |
DK0790987T3 (da) | Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer | |
EP1666469A4 (de) | Inhibitor des plasminogenaktivatorinhibitors-1 | |
EA200000614A1 (ru) | 2,3-замещенные соединения индола в качестве ингибиторов сох-2 | |
DE69722858D1 (de) | Intimale verdickungsinhibitoren | |
DK0618193T3 (da) | Nitrogenholdige, bicycliske derivater som prolyl-endopeptidaseinhibitorer | |
HUP0302193A2 (hu) | 1,4-Diazabiciklo[3.2.2]nonán-benzoxazol,-benzotiazol és -benzimidazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
PT1157998E (pt) | Compostos heterociclicos seus intermediarios e inibidores da elastase | |
ATE512154T1 (de) | Kondensiertes pyrimidinderivat und xanthinoxidaseinhibitor | |
WO2003068744A1 (fr) | Derives de la pyridine ou leurs sels, et inhibiteurs de production de citokine renfermant ces derives | |
ATE445619T1 (de) | Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren | |
ATE201402T1 (de) | Optisch aktive thiazolidinonderivate | |
ATE440100T1 (de) | Prenyl transferasinhibitoren | |
DE60239324D1 (de) | Phenyl- und pyridyl-piperidine mit tnf-wirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1452528 Country of ref document: EP |